
bioRxiv (Cold Spring Harbor Laboratory), Journal Year: 2023, Volume and Issue: unknown
Published: Oct. 20, 2023
Abstract Pulmonary tuberculosis (PTB) represents 85% of the disease burden caused by Mycobacterium (Mtb) and promotes aerosol transmission infecting about a quarter people globally. Most Mtb infections are effectively limited within primary granulomatous lesions. Containment failures lead to hematogenous spread formation post-primary destructive PTB Factors that favor survival replication in lungs after despite systemic immunity represent appealing targets for host-directed TB therapies, but currently unknown. We developed novel mouse model mimics progression chronic humans: wherein lesions form from remote lesion immunocompetent TB-susceptible B6.Sst1S mice. The mice featuring pneumonia, bronchogenic expansion broncho-occlusion closely resembling humans. Using spatial transcriptomic fluorescent multiplexed immunochemistry, we demonstrated myeloid cell populations with appearance alternatively activated macrophages, dissolution initial lymphoid follicles, accumulation de-differentiated lung epithelial cells advanced To determine whether parenchymal or oxygenation were necessary pulmonary progression, implanted spleen fragments subcutaneously serve as potential spread. (but not spleen) implants displayed characteristic organized granulomas necrosis demonstrating deleterious interactions aberrantly macrophages inflammation-injured resident cells, possibly hypoxia, oxygenation, critical determinants hosts. Necrotic also subcutaneous human tissue immune system respiratory infection. These animal models may further dissect lung-specific mechanisms host susceptibility virulent testing therapeutic interventions targeting these mechanisms.
Language: Английский